Your browser doesn't support javascript.
loading
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study.
I Ghanem, Ahmed; Woody, Neil M; Schymick, Mathew A; Joshi, Nikhil P; Geiger, Jessica L; Jillian Tsai, Chiaojung; Dunlap, Neal E; Liu, Howard Y; Burkey, Brian B; Lamarre, Eric D; Ku, Jamie A; Scharpf, Joseph; Caudell, Jimmy J; V Porceddu, Sandro; Lee, Nancy Y; Adelstein, David J; Koyfman, Shlomo A; Siddiqui, Farzan.
Afiliação
  • I Ghanem A; Department of Radiation Oncology, Henry Ford Cancer Institute, Detroit, MI, USA; Clinical Oncology Department, Faculty of Medicine, University of Alexandria, Alexandria, Egypt. Electronic address: aghanem1@hfhs.org.
  • Woody NM; Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: woodyn@ccf.org.
  • Schymick MA; Department of Radiation Oncology, Henry Ford Cancer Institute, Detroit, MI, USA. Electronic address: mschymi1@hfhs.org.
  • Joshi NP; Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: joshin@ccf.org.
  • Geiger JL; Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: geigerj@ccf.org.
  • Jillian Tsai C; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: tsaic@mskcc.org.
  • Dunlap NE; Department of Radiation Oncology, University of Louisville, School of Medicine Hospital, Louisville, KY, USA. Electronic address: neal.dunlap@louisville.edu.
  • Liu HY; Department of Head and Neck Oncology, Princess Alexandra Hospital/University of Queensland, Brisbane, Australia. Electronic address: howard.liu@health.qld.gov.au.
  • Burkey BB; Section of Head and Neck Surgery and Oncology Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: burkeyb1@ccf.org.
  • Lamarre ED; Section of Head and Neck Surgery and Oncology Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: lamarre@ccf.org.
  • Ku JA; Section of Head and Neck Surgery and Oncology Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: kuj@ccf.org.
  • Scharpf J; Section of Head and Neck Surgery and Oncology Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: scharpj@ccf.org.
  • Caudell JJ; Department of Radiation Oncology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. Electronic address: jimmy.caudell@moffitt.org.
  • V Porceddu S; Department of Head and Neck Oncology, Princess Alexandra Hospital/University of Queensland, Brisbane, Australia. Electronic address: sandro.porceddu@health.qld.gov.au.
  • Lee NY; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: leen2@mskcc.org.
  • Adelstein DJ; Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: adelstd@ccf.org.
  • Koyfman SA; Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: koyfmas@ccf.org.
  • Siddiqui F; Department of Radiation Oncology, Henry Ford Cancer Institute, Detroit, MI, USA. Electronic address: fsiddiq2@hfhs.org.
Oral Oncol ; 126: 105781, 2022 03.
Article em En | MEDLINE | ID: mdl-35183910
OBJECTIVES: To explore the influence of treatment package time(TPT) in high-risk oral cavity squamous cell carcinoma(OCSCC) receiving adjuvant radiotherapy with concurrent chemotherapy(CRT). MATERIALS AND METHODS: We queried our multi-institutional OCSCC collaborative database for cases diagnosed between 2005 and 2015 who underwent surgery followed by adjuvant CRT. All patients had high-risk features: extranodal extension(ENE) and/or positive surgical margin(PM). TPT was days between surgery to last radiotherapy fraction. Kaplan-Meier curves, log-rank p-values and multivariate analysis(MVA) were used to investigate the impact of TPT on overall(OS), disease-free(DFS), locoregional failure-free(LRFS) and distant metastases-free(DMFS) survival. RESULTS: We identified 187 cases: median age 58 (range, 24-87 years), males 66%, and ever smokers 69%. ENE and PM were detected in 85% and 32%, and oral tongue and floor of the mouth constituted 49% and 18%, respectively. Median radiotherapy and cisplatin doses received were 66 Gy and 200 mg/m2. Overall, median TPT was 98 (range, 63-162 days). OS was worse for TPT > 90-days (n = 134) than TPT ≤ 90 (n = 53) at two-(65% vs. 71%) and five-years (45% vs. 62%); p = 0.05, with similar results for DFS. No influence on LRFS or DMFS was noted. More lymph nodes(LN) dissected(P = 0.039), T3-4 disease(P = 0.017), and unplanned reoperations(P = 0.037) occurred with TPT > 90-days. On MVA, TPT in 10-day increments was independently detrimental for OS (Hazard Ratio: 1.14; 95 %Confidence Interval [1-1.28]; P = 0.043), perineural invasion, age and positive LN (p < 0.05 for all). CONCLUSION: In one of the largest multi-institutional cohorts, TPT > 90-days predicted worse OS for high-risk OCSCC receiving adjuvant CRT. All efforts are needed to optimize perioperative care and baseline conditions for favorable outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oral Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oral Oncol Ano de publicação: 2022 Tipo de documento: Article